RxDoctor Payments Data

Lolly Eldridge, MD

Obstetrics & Gynecology · Jackson, TNNPI 1285852509

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Gentleman Orthopedic Solutions at 30.4% of the total. That places this record below the midpoint for obstetrics & gynecology clinicians in TN, where the typical reported total is $906.

$220in general payments, 2019–2025

Across 7 payments — averaging $31.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gentleman Orthopedic Solutions$67
  • Exeltis, USA Inc.$46
  • Organon$37
  • Sumitomo Pharma America, Inc.$25
  • Pfizer$24
  • AbbVie$21
$352,346in research payments, 2019–2025

Across 113 payments — averaging $3118.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sebela Pharmaceuticals Inc.$169K
  • Masimo Corporation$119K
  • Sebela Women's Health Inc.$64K

What the payments were for

  • Food & beverage$220100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gentleman Orthopedic Solutions1$67
Exeltis, USA Inc.2$46
Organon1$37
Sumitomo Pharma America, Inc.1$25
Pfizer1$24
AbbVie1$21

How this compares

$220 in reported general payments places this provider in the 25th percentile of 763 obstetrics & gynecology providers in Tennessee.

See all obstetrics & gynecology providers in Tennessee

Medicare billing

Part B allowed, 2024
$39,183
Medicare patients
195
Services billed
857

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated12$5,543
Estradiol49$2,912
Clobetasol Propionate11$1,124
Ibandronate Sodium12$384
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$232
Alendronate Sodium27$102
Fluconazole11$81

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$24$5,54312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 763 obstetrics & gynecology providers in Tennessee.

Other obstetrics & gynecology in Jackson

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →